Who has invested in Antidote.me?

LBO France, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures are named among the investors backing Antidote.me.

Antidote.me Funding: $60M Raised, Seed (2026)

Antidote.me funding overview

Antidote.me is based in London, United Kingdom. Antidote.me has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in January 2026. The round record for Antidote.me runs through 2026; nothing later has been disclosed. Investors on record include LBO France, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures. 4 distinct backers are named across the disclosed rounds.

Antidote.me at a glance

Total raised: $60M
Latest round: Seed
Latest round date: January 2026
Headquarters: London, United Kingdom
Notable investors: LBO France, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures

Frequently asked about Antidote.me funding

How much has Antidote.me raised?: Antidote.me has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Antidote.me?: LBO France, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures are named among the investors backing Antidote.me.
What was the latest Antidote.me funding round?: The most recent disclosed round is a Seed, announced in January 2026.
Where is Antidote.me based?: Antidote.me is based in London, United Kingdom.
When did Antidote.me last raise?: The last disclosed Antidote.me round closed in January 2026 at Seed.

Totals shown for Antidote.me aggregate every disclosed round on file. To see how that compares, browse the companies in London and the investors behind them below.

Antidote.me Funding: $60M Raised, Seed (2026)

Antidote.me funding overview

Antidote.me at a glance

Frequently asked about Antidote.me funding

Companies related to Antidote.me (21)

Browse related funding lists (7)